Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess during the entire study period (30 days) the safety and reactogenicity of re-vaccination with the low dose influenza vaccine adjuvanted with half dose of AS03. Fluarix™ will be used as reference
Critère d'inclusion
- Re-vaccination against influenza in male and female subjects aged 18-60 years old